Ashish C. Bhatia MD, FAAD
Associate Professor of Clinical Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois; Co-Founder, Director of Clinical Research, and Co-Director, Dermatologic, Laser and Cosmetic Surgery, Oak Dermatology, Itasca, Joliet, and Naperville, IllinoisDr. Ashish Bhatia is a board-certified and fellowship-trained dermatologist and dermatologic surgeon. He is an Associate Professor of Clinical Dermatology at Northwestern University Feinberg School of Medicine in Chicago and the Director of Dermatologic, Laser, and Cosmetic Surgery at Oak Dermatology (locations in Itasca, Joliet, and Naperville, Illinois).
Dr. Bhatia is a recognized expert in dermatologic surgery and cosmetic surgery. His clinical expertise includes Mohs and reconstructive surgery, skin cancer therapy and prevention, laser surgery, skin resurfacing procedures, and cosmetic procedures including lasers, fillers, and neuromodulators. He also has a special interest in restorative procedures for adults and children with burns, surgical scars, and traumatic scars.
After receiving his medical degree from Northeastern Ohio University College of Medicine, Dr. Bhatia completed his residency in dermatology at the Medical College of Virginia Hospitals, where he served as Chief Resident. Subsequently, he completed an intensive fellowship in Mohs surgery, cutaneous oncology, and reconstruction, cosmetic, and laser surgery at SkinCare Physicians in Boston, Massachusetts.
Disclosures
- Grants/research: AbbVie; Alastin Skincare; Avita Medical; Cutera; Medline; NovaScan; Pulse Biosciences; R2 Technologies; Revance
- Consulting/advisory boards: Alastin Skincare; Allergan/AbbVie; Arcutis; Avita Medical; Bausch Health; Carpe; Cutera; Cytrellis; Emblation Ltd; Endo Aesthetics; Entrepix Medical; Evolus; Medline; MiMEDx; Obagi; Ortho Dermatologics; RBC Consultants; Revance; Solta; Sofwave; Strata Skin Sciences; Theravant Corp
- Speaker bureau: Allergan; Cutera; DermEd Foundation; Evolus; Medline; MiMEDx; Ortho Dermatologics; Paradigm Medical; Revance; Theravant Corp
- Ownership interest/shareholder: Biomarck; Carpe; Cutera; Derma MD; Genzum; SimSkin; Sonoma; Theravant Corp; Zalea
- Stock/options: AbbVie; Bausch Health; Biomarck; Carpe; Cutera; Cytrellis; Strata Skin Health
- Executive role/board member: Theravant Corp; DermEd Foundation
Recent Contributions to PracticeUpdate:
- Assessment of Comorbidities Associated With Allergic Contact Dermatitis in the United States
- Comparative Effectiveness of Ice Packs vs Topical Lidocaine–Prilocaine for Pain Control in Laser Axillary Hair Removal
- Association Between Electronic Cigarette Use and Cutaneous Wound Healing
- Racial and Ethnic Differences in Barriers to Care Among US Adults With Chronic Inflammatory Skin Diseases
- Support Provided by Dermatological Nurses Improves Outcomes in Patients With Psoriasis Treated Topically
- Factors Associated With Dermatologic Follow-Up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit
- Addition of a Monkeypox Registry to the AAD/ILDS COVID-19 Registry
- The Toll of Technology Use From the Physiologic and Psychologic Perspective
- Patient Perception of the Diagnosis Announcement and Its Impact on Patients With Primary Melanoma or BCC
- Utility of PCR for Assessment of Onychomycosis During Topical Therapy